Polydex Pharmaceuticals Limited (OTCMKTS:POLXF – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.99 and traded as low as $1.99. Polydex Pharmaceuticals shares last traded at $1.99, with a volume of 2,000 shares traded.
Polydex Pharmaceuticals Stock Performance
The stock has a 50-day moving average of $1.99 and a two-hundred day moving average of $1.99. The company has a market cap of $6.81 million and a P/E ratio of -8.27.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market.
See Also
- Five stocks we like better than Polydex Pharmaceuticals
- What Do S&P 500 Stocks Tell Investors About the Market?
- Silicon Motion Proves That AI in Motion Stays in Motion
- ETF Screener: Uses and Step-by-Step Guide
- Undervalued UnitedHealth Group Won’t Be For Long
- EV Stocks and How to Profit from Them
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
